PH30761A - An infant formulation fortified with bile salt-activated lipase. - Google Patents

An infant formulation fortified with bile salt-activated lipase.

Info

Publication number
PH30761A
PH30761A PH43285A PH43285A PH30761A PH 30761 A PH30761 A PH 30761A PH 43285 A PH43285 A PH 43285A PH 43285 A PH43285 A PH 43285A PH 30761 A PH30761 A PH 30761A
Authority
PH
Philippines
Prior art keywords
bssl
fortified
bile salt
sequence given
activated lipase
Prior art date
Application number
PH43285A
Other languages
English (en)
Inventor
Bjursell Gunner
Blackberg Lars
Olivecrona Thomas
Herell Olle
Carlson Peter
Nilsson Jeanette
Enerback Sven
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH30761A publication Critical patent/PH30761A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH43285A 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase. PH30761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
PH30761A true PH30761A (en) 1997-10-17

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43285A PH30761A (en) 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase.

Country Status (44)

Country Link
EP (1) EP0535048B1 (de)
JP (1) JPH05507201A (de)
KR (1) KR100212411B1 (de)
CN (2) CN1075113C (de)
AP (1) AP207A (de)
AT (1) ATE151077T1 (de)
AU (1) AU651979B2 (de)
BG (1) BG61165B1 (de)
CA (1) CA2083396C (de)
CZ (1) CZ287470B6 (de)
DE (1) DE69125489T2 (de)
DK (1) DK0535048T3 (de)
DZ (1) DZ1503A1 (de)
EG (1) EG19937A (de)
ES (1) ES2099159T3 (de)
FI (1) FI114639B (de)
GR (1) GR3023618T3 (de)
HK (1) HK62497A (de)
HR (1) HRP920771B1 (de)
HU (1) HU215258B (de)
IE (1) IE911844A1 (de)
IL (1) IL98273A (de)
IS (1) IS1751B (de)
JO (1) JO1694B1 (de)
LT (1) LT4020B (de)
LV (1) LV10292B (de)
MA (1) MA22166A1 (de)
MY (1) MY111245A (de)
NO (1) NO322962B1 (de)
NZ (1) NZ238223A (de)
PH (1) PH30761A (de)
PL (1) PL166534B1 (de)
PT (1) PT97836B (de)
RO (1) RO114793B1 (de)
RU (1) RU2140983C1 (de)
SE (1) SE9001985D0 (de)
SG (1) SG48078A1 (de)
SK (1) SK281089B6 (de)
TN (1) TNSN91041A1 (de)
TW (1) TW221712B (de)
UA (1) UA39165C2 (de)
WO (1) WO1991018923A1 (de)
YU (1) YU49138B (de)
ZA (1) ZA913778B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
US20090226904A1 (en) * 2005-12-01 2009-09-10 University Of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes
JP5925187B2 (ja) * 2010-04-23 2016-05-25 シナジーバ バイオファーマ コープ リソソーム蓄積症酵素
IL225095A (en) 2010-09-09 2016-05-31 Synageva Biopharma Corp Lysosomal acidic lipase for use in treating lysosomal acidic lipase deficiency in patients
RU2013123053A (ru) 2010-10-21 2014-11-27 Сведиш Орфан Биовитрум Аб (Пабл) Способ увеличения скорости роста новорожденных детей
EP2629789A1 (de) 2010-10-21 2013-08-28 Swedish Orphan Biovitrum AB (Publ) Verfahren zur erhöhung der absorption von ungesättigten fettsäuren durch menschliche kleinkinder
CA3066521A1 (en) * 2017-06-19 2018-12-27 Swedish Orphan Biovitrum Ab (Publ) Fusion protein with half-life extending polypeptide
WO2021041809A1 (en) 2019-08-30 2021-03-04 Codexis, Inc. Engineered lipase variants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000381A1 (en) * 1983-07-01 1985-01-31 Celltech Limited Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production

Also Published As

Publication number Publication date
YU49138B (sh) 2004-03-12
NZ238223A (en) 1993-05-26
LV10292A (lv) 1994-10-20
EG19937A (en) 2000-12-31
WO1991018923A1 (en) 1991-12-12
NO322962B1 (no) 2006-12-18
UA39165C2 (uk) 2001-06-15
HRP920771B1 (en) 1999-10-31
HU9203774D0 (en) 1993-03-29
TW221712B (de) 1994-03-11
LV10292B (en) 1995-08-20
SK281089B6 (sk) 2000-11-07
MY111245A (en) 1999-10-30
MA22166A1 (fr) 1991-12-31
IE911844A1 (en) 1991-12-04
HK62497A (en) 1997-05-16
EP0535048B1 (de) 1997-04-02
IL98273A (en) 2005-11-20
AU651979B2 (en) 1994-08-11
AP9100270A0 (en) 1991-07-31
ATE151077T1 (de) 1997-04-15
KR100212411B1 (en) 1999-08-02
DE69125489T2 (de) 1997-08-14
CZ164491A3 (cs) 1999-07-14
NO924528D0 (no) 1992-11-24
FI925453L (fi) 1992-11-30
GR3023618T3 (en) 1997-08-29
IS3710A7 (is) 1991-12-02
CN1326782A (zh) 2001-12-19
HUT63184A (en) 1993-07-28
TNSN91041A1 (fr) 1992-10-25
NO924528L (no) 1992-11-24
CN1075113C (zh) 2001-11-21
PL166534B1 (pl) 1995-05-31
RU2140983C1 (ru) 1999-11-10
IL98273A0 (en) 1992-06-21
ES2099159T3 (es) 1997-05-16
PT97836A (pt) 1992-02-28
LT4020B (en) 1996-08-26
ZA913778B (en) 1992-02-26
DE69125489D1 (de) 1997-05-07
JO1694B1 (en) 1992-08-09
FI925453A0 (fi) 1992-11-30
CA2083396C (en) 2006-09-19
JPH05507201A (ja) 1993-10-21
LTIP1736A (en) 1995-08-25
EP0535048A1 (de) 1993-04-07
CZ287470B6 (cs) 2000-12-13
PT97836B (pt) 1998-11-30
CA2083396A1 (en) 1991-12-02
YU95191A (sh) 1994-06-10
RO114793B1 (ro) 1999-07-30
SK164491A3 (en) 1995-07-11
HRP920771A2 (en) 1997-04-30
AU7964591A (en) 1991-12-31
BG97123A (bg) 1993-12-24
CN1064313A (zh) 1992-09-09
SG48078A1 (en) 1998-04-17
DK0535048T3 (da) 1997-09-29
AP207A (en) 1992-08-18
SE9001985D0 (sv) 1990-06-01
DZ1503A1 (fr) 2004-09-13
IS1751B (is) 2000-07-21
BG61165B1 (bg) 1997-01-31
FI114639B (fi) 2004-11-30
HU215258B (hu) 1998-11-30

Similar Documents

Publication Publication Date Title
PH30761A (en) An infant formulation fortified with bile salt-activated lipase.
WO1998014592A3 (en) Telomerase reverse transcriptase
CA2144312A1 (en) Unsaturated aliphatic dicarboxylic acids
AU2738497A (en) Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
EP0707844A3 (de) Abgabe von Zusammensetzungen zur Verstärkung der Bräunung und Besserung von UV Schäden durch Liposomen
CA2278028A1 (en) Methods for improving transformation efficiency
CA2137378A1 (en) D-enzyme compositions and methods of their use
AU1770888A (en) Treatment of periodontal disease
AU581662B2 (en) Cosmetic preparation
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
AU2670495A (en) Ifn-beta liquid formulations
PL350165A1 (en) Detergent cosmetic compositions and use
CA2306628A1 (en) Cosmetic formulations for the prevention and therapy of hair loss
EP0293766A3 (de) Emulsionen
IT8847640A0 (it) Dispositivo per la conservazione prolungata di prodotti al riparo dall'ossigeno dell'aria
EP1591528A3 (de) Verfahren und zusammensetzungen zur verabreichung und expression von interferon-alpha nukleinsäuren
EP0317279A3 (de) Peptide für die Verwendung zur Reinigung von Faktor-VIII
CA2293367A1 (en) Wax esters enriched in .omega.-3 unsaturated fatty acids, their preparation and their use
Gharavi Molecular cloning of the human lipoxygenase gene
WO2001036458A3 (en) Drosophila ced-6 homologue
IT1216383B (it) Metodo per adornare oggetti metallici,in particolare oggetti decorativi per arte funeraria o per la casa, e oggetti cosi'ottenuti
WO2002006328A3 (en) Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
RU99114027A (ru) Нуклеиново-кислотные и аминокислотные последовательности helicobacter pylory и их вакцинные композиции
IT8719399A0 (it) Metodo e prodotti per indurre sterilita' maschile nelle piante.
HUT52570A (en) Polishing and stabilizing composition for sulphur-acid-hydrogene-peroxid pickling of copper and copper-alloys